Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

Blood (2019) 134 (21): 1821–1831.

https://doi.org/10.1182/blood.2019001187

Published: 2019

Includes: Supplemental data

Journal Articles

Combination of the MEK Inhibitor Trametinib and Pyrvinium Pamoate Efficiently Targets RAS Pathway-Mutated Acute Myeloid Leukemia in Preclinical Models

Blood (2019) 134 (Supplement_1): 2671.

https://doi.org/10.1182/blood-2019-123418

Published: 2019

Journal Articles

Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group

Blood (2018) 132 (Supplement 1): 943.

https://doi.org/10.1182/blood-2018-99-115085

Published: 2018

Journal Articles

Clonal B-Cell Lymphocytosis with Marginal Zone Features and Splenic Marginal Zone Lymphoma Share a Similar Cytogenetic and Mutational Profile

Paul Legendre, MD, Olivier Kosmider, PharmD, PhD, Coralie Derrieux, PharmD, Nicolas Chapuis, PharmD, PhD, Isabelle Radford-Weiss, PharmD, Hélène Guermouche, Barbara Burroni, MD, Julie Bruneau, MD PhD, Bénédicte Deau, MD, Richard Delarue, MD, Olivier Hermine, MD PhD, Didier Bouscary, MD PhD, David Sibon, MD PhD

Blood (2016) 128 (22): 2962.

https://doi.org/10.1182/blood.V128.22.2962.2962

Published: 2016

Journal Articles

An Early Thymic Precursor Phenotype Predicts Outcome Exclusively in HOXA-Overexpressing Adult T-ALL: A GRAALL Study

Jonathan Bond, MDPhD, Tony Marchand, MD, Aurore Touzart, MD, Agata Cieslak, Amélie Trinquand, MD, Laurent Sutton, MD, Isabelle Radford-Weiss, Salvatore Spicuglia, PhD, Hervé Dombret, MD, Elizabeth Macintyre, MD PhD, Norbert Ifrah, MD, Jean-François Hamel, Vahid Asnafi, MDPhD

Blood (2015) 126 (23): 808.

https://doi.org/10.1182/blood.V126.23.808.808

Published: 2015

Journal Articles

A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency

Blood (2013) 122 (23): 3713–3722.

https://doi.org/10.1182/blood-2013-06-508267

Published: 2013

Includes: Supplemental data

Journal Articles

NOTCH1 Mutations Are Associated With The 14q Deletion In Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Blood (2013) 122 (21): 2561.

https://doi.org/10.1182/blood.V122.21.2561.2561

Published: 2013

Journal Articles

Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia

Blood (2013) 122 (20): 3521–3532.

https://doi.org/10.1182/blood-2013-03-493163

Published: 2013

Includes: Supplemental data

Journal Articles

Targeted Therapy in CMML: Complete Molecular Response to Sorafenib in a Patient with a FLT3-ITD Malignant Hematopoiesis

Olivier Kosmider, MD, PhD, Nicolas Chapuis, Sophie Kaltenbach, Romain Coriat, Pascaline boudou-Rouquette, Lise Willems, Virginie Chesnais, Isabelle Radford-Weiss, Valérie Bardet, Patrick Mayeux, Jerome Tamburini, Michaela Fontenay, MD, PhD, Didier Bouscary

Blood (2012) 120 (21): 4786.

https://doi.org/10.1182/blood.V120.21.4786.4786

Published: 2012

Journal Articles

A Mendelian Predisposition to B Cell Lymphoma Caused by IL-10R2 Deficiency

Blood (2012) 120 (21): 5092.

https://doi.org/10.1182/blood.V120.21.5092.5092

Published: 2012

Journal Articles

Extensive molecular mapping of TCRα/δ- and TCRβ-involved chromosomal translocations reveals distinct mechanisms of oncogene activation in T-ALL

Blood (2012) 120 (16): 3298–3309.

https://doi.org/10.1182/blood-2012-04-425488

Published: 2012

Includes: Supplemental data

Journal Articles

Abnormalities of the Hematopoietic Stem Cell Compartment in Children After in Utero Exposure to AZT

Isabelle Andre-Schmutz, PhD, Liliane Dal Cortivo, Emmanuelle M. Six, PhD, Sophie Kaltenbach, Isabelle Radford-Weiss, Nicolas Cagnard, Fabienne Cocchiarella, Alexandra Benachi, Laurent Mandelbrot, Fulvio Mavilio, Marina Cavazzana-Calvo, MD, PhD, Stéphane Blanche, MD

Blood (2011) 118 (21): 1123.

https://doi.org/10.1182/blood.V118.21.1123.1123

Published: 2011

Journal Articles

Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC

Blood (2011) 117 (23): 6109–6119.

https://doi.org/10.1182/blood-2010-11-317073

Published: 2011

Journal Articles

Three Novel AML Cases Harboring the Semi-Cryptic t(7;21)(p22;q22) Translocation Expressing RUNX1-USP42 Fusion Transcripts Associated with Diploidy/Tetraploidy and/or 5q Alterations: a Probably Underestimated Combination

Eric Jeandidier, Carine Gervais, Isabelle Radford-Weiss, Catherine Gangneux, Valerie Rimelen, Georges Jung, Ines Harzallah, Bernard Drenou, Bruno Lioure, Laurent Mauvieux

Blood (2010) 116 (21): 2708.

https://doi.org/10.1182/blood.V116.21.2708.2708

Published: 2010

Journal Articles

Specific Chromosomal IG Translocations Have Different Prognosis In Chronic Lymphocytic Leukemia

Blood (2010) 116 (21): 582.

https://doi.org/10.1182/blood.V116.21.582.582

Published: 2010

Journal Articles

Chromosomal Abnormalities in Transformed Ph-Negative Myeloproliferative Neoplasm Are Independent of the JAK2 and the TET2 Statuses.

Blood (2009) 114 (22): 2900.

https://doi.org/10.1182/blood.V114.22.2900.2900

Published: 2009

Journal Articles

Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell–immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype

Marina Cavazzana-Calvo, Frédérique Carlier, Françoise Le Deist, Estelle Morillon, Pierre Taupin, David Gautier, Isabelle Radford-Weiss, Sophie Caillat-Zucman, Bénédicte Neven, Stephane Blanche, Rémi Cheynier, Alain Fischer, Salima Hacein-Bey-Abina

Blood (2007) 109 (10): 4575–4581.

https://doi.org/10.1182/blood-2006-07-029090

Published: 2007

Journal Articles

HOX11L2 / TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32)

Xin-Ying Su, Véronique Della-Valle, Isabelle Andre-Schmutz, Claudie Lemercier, Isabelle Radford-Weiss, Paola Ballerini, Michel Lessard, Marina Lafage-Pochitaloff, Francine Mugneret, Roland Berger, Serge P. Romana, Olivier A. Bernard, Virginie Penard-Lacronique

Blood (2006) 108 (13): 4198–4201.

https://doi.org/10.1182/blood-2006-07-032953

Published: 2006

Includes: Supplemental data

Journal Articles

Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Blood (2006) 109 (8): 3451–3461.

https://doi.org/10.1182/blood-2006-08-041012

Published: 2006

Includes: Supplemental data

Journal Articles

The t(14;19)(q32;q13) Translocation in B Lymphoproliferative Disorders: A Continuum from Chronic Lymphocytic Leukemia (CLL) to Marginal Zone Lymphoma (MZL)?.

Florence Nguyen-Khac, MD, PhD, Elise Chapiro, MD, Isabelle Radford-Weiss, MD, Christian Bastard, MD,PhD, Leroux Dominique, MD,PhD, Evelyne Callet-Bauchu, MD,PhD, Pascaline Talmant, MD, Isabelle Luquet, MD,PhD, Mozziconacci Marie-Joelle, MD,PhD, Lessard Michel, MD,PhD, Raynaud D. Sophie, MD,PhD, Frederic Davi, MD,PhD, Helene Merle-Beral, MD,PhD, Francoise Berger, MD,PhD, Roland Berger, MD,PhD

Blood (2006) 108 (11): 4944.

https://doi.org/10.1182/blood.V108.11.4944.4944

Published: 2006

NARROW

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

Combination of the MEK Inhibitor Trametinib and Pyrvinium Pamoate Efficiently Targets RAS Pathway-Mutated Acute Myeloid Leukemia in Preclinical Models

Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group

Clonal B-Cell Lymphocytosis with Marginal Zone Features and Splenic Marginal Zone Lymphoma Share a Similar Cytogenetic and Mutational Profile

An Early Thymic Precursor Phenotype Predicts Outcome Exclusively in HOXA-Overexpressing Adult T-ALL: A GRAALL Study

A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency

NOTCH1 Mutations Are Associated With The 14q Deletion In Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia

Targeted Therapy in CMML: Complete Molecular Response to Sorafenib in a Patient with a FLT3-ITD Malignant Hematopoiesis

A Mendelian Predisposition to B Cell Lymphoma Caused by IL-10R2 Deficiency

Extensive molecular mapping of TCRα/δ- and TCRβ-involved chromosomal translocations reveals distinct mechanisms of oncogene activation in T-ALL

Abnormalities of the Hematopoietic Stem Cell Compartment in Children After in Utero Exposure to AZT

Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC

Three Novel AML Cases Harboring the Semi-Cryptic t(7;21)(p22;q22) Translocation Expressing RUNX1-USP42 Fusion Transcripts Associated with Diploidy/Tetraploidy and/or 5q Alterations: a Probably Underestimated Combination

Specific Chromosomal IG Translocations Have Different Prognosis In Chronic Lymphocytic Leukemia

Chromosomal Abnormalities in Transformed Ph-Negative Myeloproliferative Neoplasm Are Independent of the JAK2 and the TET2 Statuses.

Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell–immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype

HOX11L2 / TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32)

Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

The t(14;19)(q32;q13) Translocation in B Lymphoproliferative Disorders: A Continuum from Chronic Lymphocytic Leukemia (CLL) to Marginal Zone Lymphoma (MZL)?.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only